In addition, it was reported that the NF-κB pathway (Okamoto et al., 2007) played an important role in contributing to the NAFLD pathogenic process, and may be a possible target for alleviation of NASH (Salamone et al., 2012a). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.